Direct‐acting antivirals for chronic hepatitis C
enfresMillions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive...enmshrfresDirect‐acting antivirals for chronic hepatitis C Background Millions of people...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017/09/18
|
| In: |
The Cochrane database of systematic reviews
Year: 2017, Issue: 9 |
| ISSN: | 1469-493X |
| DOI: | 10.1002/14651858.CD012143.pub3 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1002/14651858.CD012143.pub3 Verlag, Volltext: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012143.pub3/full 
|
| Author Notes: | Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C |
| Summary: | enfresMillions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive...enmshrfresDirect‐acting antivirals for chronic hepatitis C Background Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Numerous previous... |
|---|---|
| Item Description: | Gesehen am 09.07.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1469-493X |
| DOI: | 10.1002/14651858.CD012143.pub3 |